News

Joe Buzzett Takes the Helms as NAC Executive Committee Chair

Joe Buzzett Takes the Helms as NAC Executive Committee Chair

Joe Buzzett Takes the Helms as NAC Executive Committee Chair

The National Armaments Consortium (NAC) has recently announced the election of Joe Buzzett as the new Chair of its Executive Committee (ExCom). This leadership change marks a significant step for the NAC, which represents over 1,000 members, including large companies, small businesses, and universities. The ExCom aims to inspire collaboration and innovation within the armaments industry.

Role of the NAC in Defense Innovation

The NAC is recognized as a premier organization dedicated to delivering armaments innovation to the Department of Defense (DoD). It serves as a vital bridge that connects a diverse array of innovative companies and academic institutions under several Other Transaction Agreements (OTA) with the DoD. This collaborative framework fosters innovation not only among established contractors but also among smaller enterprises and academic institutions.

Mr. Buzzett's Vision

In his acceptance, Mr. Buzzett expressed his commitment to advancing NAC's mission. "I am honored to take on this role and look forward to working with our members to foster collaboration and innovation in the armaments industry," he stated. His excitement stems from the ongoing advancements made with government cohorts and ATI, the Consortium Management Firm (CMF), aimed at streamlining the OTA process. This initiative is designed to bring efficient solutions to the warfighter, allowing NAC's members and the U.S. government to deliver cutting-edge solutions that give troops a decisive edge on the battlefield.

Joe Buzzett's Background and Experience

Joe Buzzett currently serves as the Chief Technology Officer at General Dynamics Ordnance and Tactical Systems. In this pivotal role, he oversees development strategies across all Strategic Business Units within the company. With over 35 years of extensive experience at General Dynamics and its predecessor companies, he has deep knowledge in research and development essential for the armaments field. Mr. Buzzett began his career in 1988 at General Defense Corporation as a research and development engineer.

The New Executive Committee Formation

The term of the newly elected ExCom commenced on October 1. Its composition features a robust blend of experts:

  • Joe Buzzett, General Dynamics – Ordnance and Tactical Systems (Chair)
  • Cathy Dickens, COLSA Corp.
  • Dr. David Robinson, Corvid Technologies
  • Steve Dart, Day & Zimmermann
  • Dr. Jason Gilliam, i3
  • Steve Cornelius, Kratos Defense
  • Dr. Paritosh Dave, Leidos
  • Karl Lewis, Lewis Machine and Tool Company, Inc.
  • Noel McCormick, McCormick Stevenson Corporation
  • Wendy Hummers, National Technical Systems, Inc.
  • Rollie Dohrn, Northrop Grumman Innovation Systems
  • Dr. Timothy Eden, Pennsylvania State University

Access to OTAs for NAC Members

NAC members enjoy the benefit of three OTAs sponsored by various government partners:

  • The Department of Defense Ordnance Technology Consortium (DOTC): This initiative collaborates with the U.S. Army’s Close Combat Development Command to create innovative solutions for future weaponry. The objective is to enhance our warfighter's capabilities effectively.
  • The Aviation and Missile Technology Consortium (AMTC): Partnering with the U.S. Army, AMTC focuses on developing next-generation missile technologies. This collaboration fosters the integration of advanced techniques and processes into effective weapon systems.
  • The Naval Energetic Systems and Technologies Program (NEST): Collaborating with the Naval Surface Warfare Center, NEST addresses significant energetic-related challenges facing national security.

About NAC

The National Armaments Consortium (NAC) stands as one of the largest collaborative organizations partnering with the DOD to advance armament technologies crucial for national security. The NAC emphasizes rapid technology transition to the warfighter, promotes innovation, and fosters a community of top technologists, all while ensuring collaboration among government, industry, and academia.

Frequently Asked Questions

Who is Joe Buzzett?

Joe Buzzett is the newly elected Chair of the National Armaments Consortium’s Executive Committee and serves as the Chief Technology Officer at General Dynamics Ordnance and Tactical Systems.

What is the role of the National Armaments Consortium?

The NAC focuses on fostering innovation and collaboration in the armaments industry, bringing together members from diverse sectors to support the DoD.

What is the significance of the Executive Committee?

The Executive Committee directs the NAC's initiatives and strategies, helping to drive advancements in defense-related technologies and collaboration.

What are OTAs, and why are they important?

Other Transaction Agreements (OTAs) are critical collaborations between the government and private entities that facilitate the development of technology and innovation in support of military operations.

How can organizations benefit from joining NAC?

Membership in NAC provides access to collaborative projects, funding opportunities, and a network of over 1,000 industry leaders committed to advancing U.S. defense technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading